NEW YORK (Reuters) - The research chiefs of betrothed drugmakers
Pfizer Inc and Allergan say the proposed combination of their
experimental drugs deserves more credit, includi...
http://rekinstantpaydayloans.com/pfizer-allergan-say-combined-drug-pipeline-underappreciated/
When a biotech company with one product in development misses its
milestones, investors typically don’t throw more money at it. Not so
with the newly renamed Millendo Therap...
http://www.xconomy.com/detroit-ann-arbor/2016/01/05/formerly-atterocor-millendo-changes-name-strategy-and-nabs-62m/
Paul Zhang is a Managing Director in the Life Sciences practice. He
began his professional career in the pharmaceutical industry; over the
span of seven years, his diverse res...
http://www.navigant.com/professionals/z/zhang-paul/
http://www.hightimes.com/read/dea-allows-cannabis-...
[http://www.hightimes.com/read/dea-allows-cannabis-imports-facilitate-big-pharma-marijuana]
DEA ALLOWS CANNABIS IMPORTS ...
https://forum.grasscity.com/marijuana-news-usa/1392114-dea-allowing-extract-importation.html
European, North American and Asian leaders from industry, government,
science and advocacy convene in Lausanne for critical discussions
Lausanne, Switzerland – On December...
http://www.usagainstalzheimers.org/press/global-leaders-dementia-meet-stop-alzheimers-2025